Humacyte Ownership | Who Owns Humacyte?

Overview Forecast RevenueFinancials Chart Transcripts

Humacyte Ownership Summary

Humacyte is owned by 28.82% institutional investors, 27.73% insiders, and 43.45% retail investors. Blackrock is the largest institutional shareholder, holding 6.60% of HUMA shares. SPDR® S&P Biotech ETF is the top mutual fund, with 2.17% of its assets in Humacyte shares.

HUMA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Humacyte	28.82%	27.73%	43.45%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	7.14M	6.60%	$34.27M
Vanguard group	4.73M	4.37%	$22.70M
State street	2.87M	2.65%	$13.77M
Geode capital management	1.86M	1.72%	$8.93M
Millennium management	1.60M	1.48%	$7.68M
Nuveen asset management	1.24M	1.15%	$5.97M
Two sigma investments, lp	1.14M	1.05%	$5.48M
Goldman sachs group	761.58K	0.70%	$3.66M
Voloridge investment management	687.30K	0.63%	$3.30M
Charles schwab investment management	654.37K	0.60%	$3.14M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Endowment wealth management	100.52K	0.35%	$482.49K
Monashee investment management	280.00K	0.17%	$1.34M
United asset strategies	218.31K	0.10%	$1.05M
Hamilton lane advisors	21.89K	0.08%	$105.09K
Gsa capital partners llp	224.18K	0.08%	$1.08M
Ars investment partners	116.42K	0.05%	$558.81K
Entrypoint capital	5.18K	0.04%	$24.86K
Virtu financial	103.16K	0.03%	$495.00K
Nverses capital	5.90K	0.02%	$28.32K
Jump financial	160.30K	0.02%	$769.43K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	7.14M	0.00%	2.35M
State street	2.87M	0.00%	1.66M
Millennium management	1.60M	0.00%	1.33M
Nuveen asset management	1.24M	0.00%	1.16M
Two sigma investments, lp	1.14M	0.01%	1.12M

Top Sellers

Holder	Shares	% Assets	Change
Aigh capital management	-	-	-2.16M
Sio capital management	-	-	-2.00M
Monashee investment management	280.00K	0.17%	-720.00K
Renaissance	-	-	-600.30K
Prescott general partners	-	-	-568.25K

New Positions

Holder	Shares	% Assets	Change	Value
Voloridge investment management	687.30K	0.01%	687.30K	$3.30M
Jump financial	160.30K	0.02%	160.30K	$769.43K
Ars investment partners	116.42K	0.05%	116.42K	$558.81K
Rafferty asset management	104.30K	0.00%	104.30K	$500.62K
Corebridge financial	47.29K	0.00%	47.29K	$227.00K

Sold Out

Holder	Change
First command advisory services	-150.00
Hexagon capital partners	-200.00
Pacer advisors	-593.00
Comerica bank	-1.05K
Metropolitan life insurance co/ny	-1.48K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	129	27.72%	31,200,461	33.99%	28	5.69%	97	110.87%	14	-58.82%
Mar 31, 2024	101	12.22%	23,285,302	30.90%	22	7.61%	46	2.22%	34	100.00%
Dec 31, 2023	90	4.65%	17,788,291	7.17%	17	6.67%	45	-13.46%	17	30.77%
Sep 30, 2023	86	11.69%	16,598,429	12.69%	16	7.89%	52	10.64%	13	18.18%
Jun 30, 2023	77	11.59%	14,729,897	22.11%	14	10.45%	47	30.56%	11	-38.89%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
SPDR® S&P Biotech ETF	2.72M	2.17%	30.13K
Vanguard Total Stock Mkt Idx Inv	2.59M	2.07%	-
iShares Russell 2000 ETF	2.31M	1.84%	-5.18K
Vanguard Institutional Extnd Mkt Idx Tr	1.23M	0.98%	18.42K
Fidelity Small Cap Index	899.70K	0.72%	-22.98K
iShares Russell 2000 Growth ETF	789.39K	0.63%	-
Nuveen Quant Small Cap Equity R6	728.27K	0.61%	-
iShares Biotechnology ETF	654.69K	0.52%	-3.91K
State St Russell Sm/Mid Cp® Indx NL Cl C	648.52K	0.52%	-19.30K
Fidelity Extended Market Index	519.30K	0.41%	57.45K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 10, 2024	Sebelius Kathleen	-	Sell	$19.66K
Sep 10, 2024	Sebelius Kathleen	-	Sell	$8.34K
Sep 09, 2024	Dougan Brady W	-	Sell	$854.76K
Sep 10, 2024	Dougan Brady W	-	Sell	$1.51M
Sep 09, 2024	Niklason Laura E	President, CEO and Director	Sell	$854.76K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	3	13
2024 Q2	8	18
2023 Q4	-	-
2023 Q3	-	11
2023 Q2	1	11

HUMA Ownership FAQ

Who Owns Humacyte?

Humacyte shareholders are primarily institutional investors at 28.82%, followed by 27.73% insiders and 43.45% retail investors. The average institutional ownership in Humacyte's industry, Biotech Stocks , is 44.97%, which Humacyte falls below.

Who owns the most shares of Humacyte?

Humacyte’s largest shareholders are Blackrock (7.14M shares, 6.60%), Vanguard group (4.73M shares, 4.37%), and State street (2.87M shares, 2.65%). Together, they hold 13.62% of Humacyte’s total shares outstanding.

Does Blackrock own Humacyte?

Yes, BlackRock owns 6.60% of Humacyte, totaling 7.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 34.27M$. In the last quarter, BlackRock increased its holdings by 2.35M shares, a 49.10% change.

Who is Humacyte’s biggest shareholder by percentage of total assets invested?

Endowment wealth management is Humacyte’s biggest shareholder by percentage of total assets invested, with 0.35% of its assets in 100.52K Humacyte shares, valued at 482.49K$.

Who is the top mutual fund holder of Humacyte shares?

SPDR® S&P Biotech ETF is the top mutual fund holder of Humacyte shares, with 2.17% of its total shares outstanding invested in 2.72M Humacyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools